Transplantační medicína

Consulta la guía para HCP sobre los servicios de inmunopruebas de Nexviazyme®: recomendaciones, tipos de prueba y procedimiento de acceso. 

Join Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across diverse Type 2 diabetes populations, including older adults and those with renal impairment.

DO. 13.08.2026

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).² The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.^1,2,3

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).² The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.^1,2,3

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).² The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.^1,2,3

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).² The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.^1,2,3

Film omawia znaczenie simplifikacji leczenia cukrzycy typu 2. Prof. Martin Haluzik zwraca uwagę, że terapia powinna być dostosowana do potrzeb i stylu życia pacjenta, aby była skuteczna i łatwa do przestrzegania.

Missed this webinar? You can now watch the recording of the webinar to learn about the role of biologics in severe asthma and COPD¹ through real-world clinical cases presented by a panel of expert clinicians.